Aurobindo Pharma Corporate Film

(13:14)

Aurobindo Pharma: An Apple In A Basket Of Oranges?

(8:12)

'Big Bull' Rakesh Jhunjhunwala Questions Aurobindo Pharma's Management

(4:56)

Aurobindo Pharma USA recalls 2 lots of blood medication

(39)

Aurobindo Pharma | Corporate Video | Raasta Studios

(8:42)

Aurobindo pharma - buy buy buy

(8:11)

Aurobindo Pharma Surges After Its Arm CuraTeQ Gets EMA Nod For Filgrastim Biosimilar | CNBC TV18

(1:13)

Aurobindo Pharma Announces Entry Into The Domestic Formulations Business

(46)

Aurobindo Pharma Ltd Q1 FY2024-25 Earnings Conference Call

(53:43)

U.S. FDA Issues 10 Observations To Aurobindo Pharma Under Form 483 | Halftime Report | CNBC-TV18

(2:31)

We Have Made Significant Inroads In Mid-Tier Pharma Companies: Indegene | CNBC TV18

(4:37)

CLSA Upgrades Aurobindo Pharma To 'Outperform', Cuts Target Price To Rs 1,400

(1:19)

Allied Blenders, Bridage Ent, Tata Motors, Arvind Smart \u0026 More: Stocks To Watch In Trade

(9:41)

See A Lot Of Potential In The Biologics Space: Aurobindo Pharma | N18V | CNBC TV18

(7:48)

Buy, Sell Or Hold These Pharma Stocks In 2025 I Expert's Advice On Pharma Stocks

(4:15)

Alembic Pharmaceuticals, Zomato, Aurobindo Pharma, Escorts Kubota in Focus

(3:40)

YOUR STOCKS | Should One Hold AUROBINDO PHARMA Stock for Long? | CNBC TV18

(9:47)

Aurobindo Pharma Surges As Eugia Steriles' Andhra Facility Gets First US FDA Approval For Injectable

(1:37)

US Business Was Impacted By Seasonality In Q1FY25: Aurobindo Pharma | CNBC TV18

(10:40)

Aurobindo Pharma Under Pressure After US FDA Issues Warning Letter For Eugia Unit III | CNBC TV18

(2:35)

Sharad Avasthi Breaks Down Pharma’s Future. Lupin, Aurobindo Pharma, Piramal, Syngene, Dr Reddy's

(3:43)

Chartbuster Stocks Today: Aurobindo Pharma, Dr Reddy's Breakout Amid Market Fall | Stock Market

(2:39)

Aurobindo Pharma gets VAI classification, US FDA gives nod to two facilities

(1:52)

Aurobindo Pharma - A wealth compounder in the making? Find out why we like this company!

(7:14)

Aurobindo Pharma Slips In Trade After US FDA Issues 10 Observations To The API Unit In Telangana

(1:16)

Aurobindo Pharma Temporarily Halts Production At Eugia’s Unit-III After 9 US FDA Observations

(1:16)